Corrigendum: Hinokiflavone Inhibits Growth of Esophageal Squamous Cancer By Inducing Apoptosis via Regulation of the PI3K/AKT/mTOR Signaling Pathway

Corrigendum: Hinokiflavone Inhibits Growth of Esophageal Squamous Cancer By Inducing Apoptosis via Regulation of the PI3K/AKT/mTOR Signaling Pathway

Bibliographic Details
Main Authors:	Jida Guo, Shengqiang Zhang, Jun Wang, Pengfei Zhang, Tong Lu, Linyou Zhang
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2022-07-01
Series:	Frontiers in Oncology
Subjects:	esophageal cancer hinokiflavone apoptosis KEGG analysis molecular docking PI3K/AKT/mTOR signal pathway
Online Access:	https://www.frontiersin.org/articles/10.3389/fonc.2022.970020/full

Similar Items

Hinokiflavone Inhibits Growth of Esophageal Squamous Cancer By Inducing Apoptosis via Regulation of the PI3K/AKT/mTOR Signaling Pathway
by: Jida Guo, et al.
Published: (2022-02-01)

PI3K/Akt/mTOR Signaling Pathway in Blood Malignancies—New Therapeutic Possibilities
by: Wojciech Wiese, et al.
Published: (2023-11-01)

Targeting PI3K/Akt/mTOR Signaling In Cancer
by: Camillo ePorta, et al.
Published: (2014-04-01)

Roles of PI3K/AKT/mTOR Axis in Arteriovenous Fistula
by: Stefano Ratti, et al.
Published: (2022-02-01)

AKTivation of the PI3K/AKT/mTOR signaling pathway by KSHV
by: Aadra P Bhatt, et al.
Published: (2013-01-01)

PI3K/AKT/mTOR pathway in Angiogenesis
by: Jayashree eKarar, et al.
Published: (2011-12-01)

Cyclophosphamide Inhibits PI3K/AKT/mTOR Signaling Pathway in Mice Kidneys
by: Gulsah Albayrak, et al.
Published: (2018-12-01)

The PI3K-Akt-mTOR Signaling Pathway in Human Acute Myeloid Leukemia (AML) Cells
by: Ina Nepstad, et al.
Published: (2020-04-01)

Targeting PI3K/Akt/mTOR Pathway by Different Flavonoids: A Cancer Chemopreventive Approach
by: Torki A. Zughaibi, et al.
Published: (2021-11-01)

Sinomenine inhibits the growth of melanoma by enhancement of autophagy via PI3K/AKT/mTOR inhibition
by: Sun Z, et al.
Published: (2018-08-01)

PI3K/AKT/mTOR-Targeted Therapy for Breast Cancer
by: Kunrui Zhu, et al.
Published: (2022-08-01)

Targeting the PI3K/Akt/mTOR Pathway in Hepatocellular Carcinoma
by: Eun Jin Sun, et al.
Published: (2021-11-01)

Inhibitors of the PI3K/Akt/mTOR Pathway in Prostate Cancer Chemoprevention and Intervention
by: Nazanin Momeni Roudsari, et al.
Published: (2021-08-01)

Expert consensus on the clinical application of PI3K/AKT/mTOR inhibitors in the treatment of advanced breast cancer
by: The Society of Clinical Research of Oncology Medications of China Anticancer Association, et al.
Published: (2022-06-01)

Targeting PI3K/AKT/mTOR Signaling Pathway in Breast Cancer
by: Huayi Li, et al.
Published: (2021-07-01)

Recent Advances in Dual PI3K/mTOR Inhibitors for Tumour Treatment
by: Xianbo Wu, et al.
Published: (2022-05-01)

The Importance of the PI3K/AKT/MTOR Pathway in the Progression of Ovarian Cancer
by: Charles N. Landen, et al.
Published: (2013-04-01)

Metformin Attenuates UVA-Induced Skin Photoaging by Suppressing Mitophagy and the PI3K/AKT/mTOR Pathway
by: Qiuyan Chen, et al.
Published: (2022-06-01)

Downregulation of PI3K/AKT/mTOR Pathway in Juglone-Treated Bovine Oocytes
by: Marwa El-Sheikh, et al.
Published: (2023-01-01)

Inhibition of the AKT/mTOR pathway negatively regulates PTEN expression via miRNAs
by: Wan Linyan, et al.
Published: (2022-10-01)

Targeting PI3K/Akt/mTOR in AML: Rationale and Clinical Evidence
by: Salihanur Darici, et al.
Published: (2020-09-01)

Dexmedetomidine suppresses sevoflurane anesthesia-induced neuroinflammation through activation of the PI3K/Akt/mTOR pathway
by: Nan Wang, et al.
Published: (2019-07-01)

PI3K/AKT/mTOR signaling transduction pathway and targeted therapies in cancer
by: Antonino Glaviano, et al.
Published: (2023-08-01)

PI3K/Akt/mTOR Signaling Pathway as a Target for Colorectal Cancer Treatment
by: Premila D. Leiphrakpam, et al.
Published: (2024-03-01)

PI3K/Akt/mTOR Signaling Pathway: Role in Esophageal Squamous Cell Carcinoma, Regulatory Mechanisms and Opportunities for Targeted Therapy
by: Qian Luo, et al.
Published: (2022-03-01)

Connectivity Map Analysis Indicates PI3K/Akt/mTOR Inhibitors as Potential Anti-Hypoxia Drugs in Neuroblastoma
by: Paolo Uva, et al.
Published: (2021-06-01)

Impacts of Oxidative Stress and PI3K/AKT/mTOR on Metabolism and the Future Direction of Investigating Fucoidan-Modulated Metabolism
by: Jun-Ping Shiau, et al.
Published: (2022-05-01)

Addressing the Reciprocal Crosstalk between the AR and the PI3K/AKT/mTOR Signaling Pathways for Prostate Cancer Treatment
by: Fabio Raith, et al.
Published: (2023-01-01)

Ropivacaine inhibits wound healing by suppressing the proliferation and migration of keratinocytes via the PI3K/AKT/mTOR Pathway
by: Xiaoyang Wu, et al.
Published: (2022-04-01)

Orf virus induces complete autophagy to promote viral replication via inhibition of AKT/mTOR and activation of the ERK1/2/mTOR signalling pathway in OFTu cells
by: Lijun Lv, et al.
Published: (2023-03-01)

Rapamycin Prevents cyclophosphamide-induced Over-activation of Primordial Follicle pool through PI3K/Akt/mTOR Signaling Pathway in vivo
by: Linyan Zhou, et al.
Published: (2017-08-01)

Small biomarkers with massive impacts: PI3K/AKT/mTOR signalling and microRNA crosstalk regulate nasopharyngeal carcinoma
by: Hai-Long LI, et al.
Published: (2022-07-01)

Brassinin Represses Invasive Potential of Lung Carcinoma Cells through Deactivation of PI3K/Akt/mTOR Signaling Cascade
by: Min Hee Yang, et al.
Published: (2019-04-01)

Upregulation of CENPM facilitates lung adenocarcinoma progression via PI3K/AKT/mTOR signaling pathway
by: Liu Chao, et al.
Published: (2021-12-01)

PIM Kinases and Their Relevance to the PI3K/AKT/mTOR Pathway in the Regulation of Ovarian Cancer
by: Aziz Ur Rehman Aziz, et al.
Published: (2018-02-01)

PI3K/Akt/mTOR inhibitors in breast cancer
by: Joycelyn JX Lee, et al.
Published: (2015-12-01)

Liraglutide attenuates obese-associated breast cancer cell proliferation via inhibiting PI3K/Akt/mTOR signaling pathway
by: Alaa Alanteet, et al.
Published: (2024-01-01)

Wnt and PI3K/Akt/mTOR Survival Pathways as Therapeutic Targets in Glioblastoma
by: Amir Barzegar Behrooz, et al.
Published: (2022-01-01)

Targeting PI3K/AKT/mTOR Signaling Pathway as a Radiosensitization in Head and Neck Squamous Cell Carcinomas
by: Yu-Chieh Su, et al.
Published: (2022-12-01)

Leonurine Promotes the Osteoblast Differentiation of Rat BMSCs by Activation of Autophagy via the PI3K/Akt/mTOR Pathway
by: Bingkun Zhao, et al.
Published: (2021-02-01)